利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.015 秒)

    BACK CONTACT SOLAR CELL AND FABRICATION METHOD THEREOF
    3.
    发明申请
    BACK CONTACT SOLAR CELL AND FABRICATION METHOD THEREOF 审中-公开
    返回联系太阳能电池及其制造方法

    公开(公告)号：US20110100457A1

    公开(公告)日：2011-05-05

    申请号：US12812910

    申请日：2008-11-13

    申请人： Hwa Nyeon Kim ,  Ju Hwan Yun ,  Jong Hwan Kim ,  Bum Sung Kim ,  Ii Hyoung Jung ,  Jin Ah Kim

    发明人： Hwa Nyeon Kim ,  Ju Hwan Yun ,  Jong Hwan Kim ,  Bum Sung Kim ,  Ii Hyoung Jung ,  Jin Ah Kim

    IPC分类号： H01L31/0232 ,  H01L31/18

    CPC分类号： H01L31/022441 ,  H01L31/02168 ,  H01L31/0236 ,  H01L31/02363 ,  H01L31/02366 ,  H01L31/0682 ,  H01L31/1804 ,  Y02E10/547 ,  Y02P70/521

    摘要： The present invention discloses a back contact solar cell comprising: a first conductive type semiconductor substrate having a front surface and a rear surface of a texturing structure; an oxide layer formed on the front surface of the substrate; at least one first conductive type semiconductor region and second conductive type semiconductor region alternatively formed at predetermined intervals on the rear surface of the substrate; an oxide layer formed on the remaining rear surface of the substrate except for the first conductive type semiconductor region and the second conductive type semiconductor region; and electrodes formed on each of the first conductive type semiconductor region and the second conductive type semiconductor region.

    摘要翻译： 本发明公开了一种背接触太阳能电池，包括：具有纹理结构的前表面和后表面的第一导电类型半导体衬底; 形成在所述基板的前表面上的氧化物层; 至少一个第一导电类型半导体区域和第二导电类型半导体区域，其间隔地以预定的间隔形成在所述衬底的后表面上; 形成在除了第一导电型半导体区域和第二导电型半导体区域之外的基板的剩余背面上的氧化物层; 以及形成在第一导电类型半导体区域和第二导电类型半导体区域中的每一个上的电极。

    Mass production of secondary metabolite in plant cell culture by treatment of saccharide mixture in medium
    5.
    发明授权
    Mass production of secondary metabolite in plant cell culture by treatment of saccharide mixture in medium 有权
    通过处理培养基中的糖混合物，在植物细胞培养中大量生产次生代谢物

    公开(公告)号：US08936940B2

    公开(公告)日：2015-01-20

    申请号：US11915869

    申请日：2006-06-02

    申请人： Jin-Ah Kim ,  Chang-Heon Kim ,  Jai-Young Song ,  Ho-Joon Choi

    发明人： Jin-Ah Kim ,  Chang-Heon Kim ,  Jai-Young Song ,  Ho-Joon Choi

    IPC分类号： C12N5/00 ,  C12N5/02 ,  C12N1/38 ,  C12P17/02

    CPC分类号： C12N5/0025 ,  C12N1/38 ,  C12P17/02

    摘要： The present invention relates to a method of producing secondary metabolites with a high yield using plant cell culture, and a medium for the production of secondary metabolites. More specifically, the method of the present invention is characterized in that the plant cell culture is conducted by adding a saccharide mixture to the culture medium as a carbon source, to increase the productivity of the secondary metabolites. For example, the present invention establishes the method of increasing the productivity of secondary metabolites and shortening the culture time by the use of the mixture of glucose and fructose in the plant cell culture, thereby contributing in producing useful secondary metabolites on an industrial scale using plant cell culture.

    摘要翻译： 本发明涉及使用植物细胞培养物产生高产率的次级代谢产物的方法和用于生产次级代谢产物的培养基。 更具体地说，本发明的方法的特征在于，通过向作为碳源的培养基中添加糖混合物来进行植物细胞培养，以提高次级代谢物的生产率。 例如，本发明建立了通过在植物细胞培养物中使用葡萄糖和果糖的混合物来提高次级代谢产物的生产率并缩短培养时间的方法，从而有助于在工业规模上使用植物生产有用的次级代谢物 细胞培养。

    5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus
    7.
    发明授权
    5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus 有权
    5,6-二甲基噻吩并[2,3-d]嘧啶衍生物，其制备方法和包含其的药物组合物用于抗病毒

    公开(公告)号：US07816351B2

    公开(公告)日：2010-10-19

    申请号：US12067246

    申请日：2005-09-23

    申请人： Cheol Kyu Han ,  Jeonghyeok Yoon ,  Nam-Doo Kim ,  Jin-ah Kim

    发明人： Cheol Kyu Han ,  Jeonghyeok Yoon ,  Nam-Doo Kim ,  Jin-ah Kim

    IPC分类号： A61K31/5377 ,  C07D413/14

    CPC分类号： C07D495/04

    摘要： Disclosed herein are 5,β-dimethylthieno[2,3-d]pyrimidine derivatives useful as antiviral agents. More particularly, disclosed are 5,β-dimethylthieno[2,3-djpyrimidine derivatives represented by Formula 1, having an excellent inhibitory effect on the proliferation of hepatitis C virus (HCV), pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the prevention and treatment of hepatitis C virus (HCV), containing, as active ingredients, these compounds. The 5,6-dimethylthieno[2,3-d]pyrimidine derivatives represented by Formula 1 have an excellent effect of inhibiting the proliferation of hepatitis C virus and also have low toxicity. Thus, these compounds are available as agents for the prevention and treatment of hepatitis C.

    摘要翻译： 本文公开了可用作抗病毒剂的5'，bgr-二甲基噻吩并[2,3-d]嘧啶衍生物。 更具体地，公开了具有对丙型肝炎病毒（HCV）增殖具有优异抑制作用的式1表示的5α-二甲基噻吩并[2,3-d]嘧啶衍生物，其药学上可接受的盐，其制备方法和 用于预防和治疗丙型肝炎病毒（HCV）的药物组合物，其含有这些化合物作为活性成分。 由式1表示的5,6-二甲基噻吩并[2,3-d]嘧啶衍生物具有抑制丙型肝炎病毒增殖并且毒性低的优异效果。 因此，这些化合物可用作预防和治疗丙型肝炎的药剂。

    5,6-Dimethylthieno[2,3-Di] Pyrimidine Derivatives, the Preparation Method Thereof and the Pharmaceutical Composition Comprising the Same for Anti-Virus
    9.
    发明申请
    5,6-Dimethylthieno[2,3-Di] Pyrimidine Derivatives, the Preparation Method Thereof and the Pharmaceutical Composition Comprising the Same for Anti-Virus 有权
    5,6-二甲基噻吩并[2,3-d]嘧啶衍生物及其制备方法和包含其的药物组合物

    公开(公告)号：US20080234482A1

    公开(公告)日：2008-09-25

    申请号：US12067246

    申请日：2005-09-23

    申请人： Cheol Kyu Han ,  Jeonghyeok Yoon ,  Nam-Doo Kim ,  Jin-ah Kim

    发明人： Cheol Kyu Han ,  Jeonghyeok Yoon ,  Nam-Doo Kim ,  Jin-ah Kim

    IPC分类号： C07D495/04

    CPC分类号： C07D495/04

    摘要： Disclosed herein are 5,β-dimethylthieno[2,3-d]pyrimidine derivatives useful as antiviral agents. More particularly, disclosed are 5,β-dimethylthieno[2,3-djpyrimidine derivatives represented by Formula 1, having an excellent inhibitory effect on the proliferation of hepatitis C virus (HCV), pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the prevention and treatment of hepatitis C virus (HCV), containing, as active ingredients, these compounds. The 5,6-dimethylthieno[2,3-d]pyrimidine derivatives represented by Formula 1 have an excellent effect of inhibiting the proliferation of hepatitis C virus and also have low toxicity. Thus, these compounds are available as agents for the prevention and treatment of hepatitis C.

    摘要翻译： 本文公开了可用作抗病毒剂的5β-二甲基噻吩并[2,3-d]嘧啶衍生物。 更具体地，公开了5种由式1表示的β-二甲基噻吩并[2,3-d]嘧啶衍生物，其对丙型肝炎病毒（HCV）的增殖具有优异的抑制作用，其药学上可接受的盐，其制备方法和 用于预防和治疗丙型肝炎病毒（HCV）的药物组合物，其含有作为活性成分的这些化合物。 由式1表示的5,6-二甲基噻吩并[2,3-d]嘧啶衍生物具有抑制丙型肝炎病毒增殖并且毒性低的优异效果。 因此，这些化合物可用作预防和治疗丙型肝炎的药剂。